Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices.
pharmacists
pharmacogenomics
pharmacy
service implementation
theoretical domains framework
Journal
Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532
Informations de publication
Date de publication:
16 Dec 2021
16 Dec 2021
Historique:
received:
13
11
2021
revised:
10
12
2021
accepted:
11
12
2021
entrez:
23
12
2021
pubmed:
24
12
2021
medline:
24
12
2021
Statut:
epublish
Résumé
Research exploring the integration of pharmacogenomics (PGx) testing by pharmacists into their primary care practices (including community pharmacies) has focused on the "external" factors that impact practice implementation. In this study, additional "internal" factors, related to the capabilities, opportunities, and motivations of pharmacists that influence their ability to implement PGx testing, were analyzed. Semi-structured interview data from the Pharmacists as Personalized Medicine Experts (PRIME) study, which examined the barriers and facilitators to implementing PGx testing by pharmacists into primary care practice, were analyzed. Through thematic analysis, using the theoretical domains framework (TDF) domains as deductive codes, the authors identified the most relevant TDF domains and applied the behavioural change wheel (BCW) to generate intervention types to aid in the implementation of PGx testing. Pharmacists described how their professional identities, practice environments, self-confidence, and beliefs in the benefits of PGx impacted their ability to provide a PGx-testing service. Potential interventions to improve the implementation of the PGx service included preparing pharmacists for managing an increased patient load, helping pharmacists navigate the software and technology requirements associated with the PGx service, and streamlining workflows and documentation requirements. As interest in the wide-scale implementation of PGx testing through community pharmacies grows, additional strategies need to address the "internal" factors that influence the ability of pharmacists to integrate testing into their practices.
Identifiants
pubmed: 34941633
pii: pharmacy9040201
doi: 10.3390/pharmacy9040201
pmc: PMC8709167
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Can J Hosp Pharm. 2014 Nov;67(6):436-40
pubmed: 25548401
Am J Pharm Educ. 2011 Apr 11;75(3):51
pubmed: 21655405
P T. 2013 Oct;38(10):624-7
pubmed: 24391381
J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):172-80
pubmed: 24632932
Clin Pharmacol Ther. 2012 Oct;92(4):467-75
pubmed: 22948889
Pharmacy (Basel). 2020 Mar 28;8(2):
pubmed: 32231164
J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):539-544
pubmed: 31010787
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Per Med. 2012 Jun;9(4):387-393
pubmed: 29776256
Pharmacogenomics. 2013 Jan;14(2):165-75
pubmed: 23327577
Implement Sci. 2012 Jun 09;7:52
pubmed: 22682612
J Am Pharm Assoc (2003). 2017 Sep - Oct;57(5):624-629
pubmed: 28689706
J Am Pharm Assoc (2003). 2014 Sep-Oct;54(5):510-7, 5 p following 517
pubmed: 25148656
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Trends Genet. 2012 Oct;28(10):487-95
pubmed: 22840197
J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):189-93
pubmed: 21382809
Implement Sci. 2017 Jan 5;12(1):2
pubmed: 28057049
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
J Pers Med. 2020 Dec 24;11(1):
pubmed: 33374349
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
J Am Pharm Assoc (2003). 2015 Nov-Dec;55(6):587-594
pubmed: 26409205